Reza Karbasi Afshar1, Mahdi Ramezani Binabaj2, Mohammad Saeid Rezaee Zavareh2, Amin Saburi2, Reza Ajudani2
1 Department of Cardiovascular Diseases, Faculty of Medicine and Cardiovascular Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
2 Students' Research Committee, Baqiyatallah University of Medical Science, Tehran, Iran
Introduction: Cardiac resynchronization therapy (CRT) is a proven therapeutic method in selected patients with heart failure and systolic dysfunction which increases left ventricular function and patient survival. We designed a study that included patients undergoing coronary artery bypass graft (CABG), with and without CRT-defibrillator (CRT-D) inserting and then measured its effects on these two groups. Patients and Methods: Between 2010 and 2013, we conducted a prospective cohort study on 100 coronary artery disease patients where candidate for CABG. Then based on the receiving CRT-D, the patients were categorized in two groups; Group 1 ( n = 48, with CRT-D insertion before CABG) and Group 2 ( n = 52 without receiving CRT-D). Thereafter both of these groups were followed-up at 1-3 months after CABG for mortality, hospitalization, atrial fibrillation (AF), echocardiographic assessment, and New York Heart Association (NYHA) class level. Results: The mean age of participants in Group 1 (48 male) and in Group 2 (52 male) was 58 ± 13 and 57 ± 12 respectively. Difference between Groups 1 and 2 in cases of mean left ventricular ejection fraction (LVEF) changes and NYHA class level was significant ( P > 0.05). Hospitalization ( P = 0.008), mortality rate ( P = 0.007), and AF were significantly different between these two groups. Conclusions: The results showed that the increase in LVEF and patient's improvement according to NYHA-class was significant in the first group, and readmission, mortality rate and AF was increased significantly in the second group.
Mahdi Ramezani Binabaj
Students' Research Committee, Baqiyatallah University of Medical Science, Tehran, IR
Source of Support: None, Conflict of Interest: None
[FULL TEXT] [PDF]*